Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign paroxysmal positional vertigo (BPPV) ...
Altamira intends to partner or divest AM-125 as part of its legacy assets in a strategic pivot to its RNA delivery technology platforms HAMILTON, BERMUDA / ACCESSWIRE / April 10, 2023 / Altamira ...
Altamira Therapeutics (NASDAQ:CYTO) stock soared ~62% on Wednesday after the company said detailed results from a phase 2 trial of AM-125 (intranasal betahistine) in surgery-induced acute vestibular ...
Hamilton, Bermuda, October 13, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology ...
HAMILTON, Bermuda - Altamira Therapeutics Ltd. (NASDAQ:CYTO), a biopharmaceutical company, has drawn attention to a peer-reviewed article that endorses the use of betahistine for treating residual ...
HAMILTON, BERMUDA / ACCESSWIRE / June 15, 2023 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq:CYTO), a company dedicated to developing therapeutics that address important unmet ...
A new pill for obesity helps overweight people shed more than 4lb a week. The drug, Betahistine, is currently used to treat the dizziness disorder vertigo. But an obesity expert in Israel stumbled on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback